Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine Remethylation: Enzymatic Pathways, Metabolic Regulation, And Industrial Biosynthesis Strategies

NOV 17, 202660 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine remethylation represents a critical metabolic cycle in which homocysteine is converted back to L-methionine through enzymatic methylation, playing essential roles in cellular methylation capacity, immune function, and amino acid homeostasis. This biochemical pathway involves cobalamin-dependent and cobalamin-independent methionine synthases, requiring cofactors such as vitamin B12, folate, and vitamin B6, and is central to both human health and industrial L-methionine production strategies. Understanding the molecular mechanisms, enzymatic kinetics, and metabolic regulation of L-methionine remethylation is vital for researchers developing advanced biosynthetic routes, optimizing fermentation processes, and designing therapeutic interventions for methylation-related disorders.
Want to know more material grades? Try Patsnap Eureka Material.

Biochemical Foundations Of L-Methionine Remethylation And Methylation Capacity

L-methionine remethylation is the enzymatic process by which homocysteine is converted back to L-methionine, thereby regenerating the methyl donor S-adenosylmethionine (SAM) and sustaining cellular methylation capacity 11. This cycle is fundamental to transmethylation reactions in all living systems, as SAM serves as the principal methyl group donor for DNA methylation, protein modification, neurotransmitter synthesis, and lipid metabolism 11. The remethylation pathway operates through two distinct enzymatic routes: the cobalamin-dependent methionine synthase (encoded by metH) and the cobalamin-independent methionine synthase (encoded by metE) 10. Both enzymes catalyze the transfer of a methyl group from 5-methyltetrahydrofolate (5-MTHF) or betaine to homocysteine, regenerating L-methionine and completing the methionine cycle 10.

The physiological importance of L-methionine remethylation is underscored by its role in maintaining the SAM:SAH (S-adenosylhomocysteine) ratio, which in healthy individuals is approximately 20:1 but can decline to as low as 5:1 in severe immune deficiency states 11. This ratio is a critical determinant of methylation capacity, as elevated SAH competitively inhibits methyltransferases, thereby impairing cellular methylation reactions 11. Supplementation with L-methionine at dosages of 20–90 mg per kilogram body mass per day has been shown to enhance methylation capacity and activate immune responses in human subjects, particularly when combined with cofactors such as magnesium, folic acid, vitamin B6, and vitamin B12 7,11. The conversion of L-methionine to SAM is catalyzed by methionine adenosyltransferase and requires ATP, magnesium ions, and potassium ions, highlighting the interdependence of energy metabolism and methylation homeostasis 11.

In industrial biosynthesis, understanding the remethylation pathway is essential for optimizing microbial production of L-methionine. Recombinant microorganisms engineered to overproduce L-methionine precursors such as O-acetyl-L-homoserine or O-succinyl-L-homoserine rely on enzymatic conversion with methyl mercaptan or dimethyl disulfide (DMDS) to yield L-methionine 1,2,3. However, the energy burden of sulfur reduction from inorganic sulfate (requiring 2 ATP, 1 GTP, and 4 NADPH molecules) can be mitigated by utilizing reduced sulfur compounds, thereby improving the overall energy balance and process economics 6. The remethylation cycle in microorganisms also involves the reuse of acetate generated during O-acetyl-L-homoserine conversion, which can be reincorporated into central metabolism by engineered strains expressing L-homoserine O-acetyltransferase activity 3.

Key enzymatic activities in L-methionine remethylation include:

  • Methionine synthase (MetH/MetE): Catalyzes the final step of homocysteine remethylation using 5-MTHF as the methyl donor; MetH requires vitamin B12 as a cofactor, while MetE is cobalamin-independent 10.
  • Methionine adenosyltransferase: Converts L-methionine to SAM in the presence of ATP and magnesium, initiating the transmethylation cycle 11.
  • O-acetylhomoserine sulfhydrylase: In microbial systems, this enzyme catalyzes the reaction between O-acetyl-L-homoserine and methyl mercaptan to produce L-methionine and acetate 2,3.

The remethylation pathway is tightly regulated by feedback inhibition, substrate availability, and cofactor status. For example, elevated SAM levels inhibit methylenetetrahydrofolate reductase (MTHFR), reducing 5-MTHF synthesis and slowing remethylation 11. Conversely, folate deficiency or vitamin B12 deficiency impairs methionine synthase activity, leading to homocysteine accumulation and reduced methylation capacity 7. In therapeutic contexts, supplementation with L-methionine (1.5–5 g daily) combined with magnesium chloride (250–2500 mg), folic acid (0.6–20 mg), vitamin B6 (1.5–25 mg), and vitamin B12 (15–400 µg) has been formulated for the treatment of myalgic encephalomyelitis (chronic fatigue syndrome), leveraging the remethylation pathway to restore immune function and reduce oxidative stress 7.

Enzymatic Mechanisms And Cofactor Requirements In L-Methionine Remethylation

The enzymatic conversion of homocysteine to L-methionine is mediated by two structurally and mechanistically distinct methionine synthases, each with specific cofactor dependencies and kinetic properties 10. Cobalamin-dependent methionine synthase (MetH) is a large, multi-domain enzyme that utilizes methylcobalamin (a derivative of vitamin B12) as a prosthetic group to transfer a methyl group from 5-methyltetrahydrofolate to homocysteine 10. The catalytic cycle involves the formation of a cob(I)alamin intermediate, which is highly reactive and must be periodically reactivated by S-adenosylmethionine in a process termed "reductive methylation" 10. This reactivation step is essential to prevent enzyme inactivation due to oxidation of the cobalt center. MetH exhibits high catalytic efficiency (kcat/Km values typically in the range of 10^5–10^6 M^-1 s^-1) and is the predominant methionine synthase in mammalian tissues and many bacteria 10.

In contrast, cobalamin-independent methionine synthase (MetE) is a zinc-dependent enzyme that directly transfers a methyl group from 5-MTHF to homocysteine without requiring vitamin B12 10. MetE is structurally simpler than MetH and is found in organisms that lack the biosynthetic machinery for cobalamin synthesis, such as certain bacteria and plants 10. Although MetE has a lower catalytic efficiency than MetH (kcat/Km values typically 10^3–10^4 M^-1 s^-1), it provides a metabolic advantage in environments where vitamin B12 is scarce 10. The zinc ion in MetE coordinates the thiolate of homocysteine, facilitating nucleophilic attack on the methyl group of 5-MTHF 10.

The remethylation of homocysteine to L-methionine is tightly coupled to folate metabolism. 5-Methyltetrahydrofolate is generated by the reduction of 5,10-methylenetetrahydrofolate by methylenetetrahydrofolate reductase (MTHFR), a flavin-dependent enzyme that is allosterically inhibited by SAM 11. This feedback regulation ensures that when methylation capacity is high (i.e., SAM levels are elevated), the flux through the remethylation pathway is reduced, and homocysteine is instead directed toward the transsulfuration pathway for cysteine synthesis 11. Conversely, when SAM levels are low, MTHFR activity increases, promoting remethylation and restoring methylation capacity 11.

Cofactor requirements for optimal L-methionine remethylation include:

  • Vitamin B12 (cobalamin): Essential for MetH activity; deficiency leads to homocysteine accumulation and impaired remethylation. Recommended supplementation ratios are 1:60,000–1:300,000 (vitamin B12 to L-methionine by mass) 7.
  • Folic acid: Required for the synthesis of 5-MTHF, the methyl donor in the remethylation reaction. Supplementation ratios of 1:75–1:8000 (folic acid to L-methionine by mass) are effective in enhancing methylation capacity 7.
  • Vitamin B6 (pyridoxine): A cofactor for cystathionine β-synthase and cystathionine γ-lyase in the transsulfuration pathway, which competes with remethylation for homocysteine. Supplementation ratios of 1:60–1:3000 (vitamin B6 to L-methionine by mass) support balanced homocysteine metabolism 7.
  • Magnesium: Required for methionine adenosyltransferase activity and ATP-dependent SAM synthesis. Magnesium chloride or magnesium carbonate is typically supplemented at a ratio of 1:2–1:6 (magnesium compound to L-methionine by mass) 7.

In microbial biosynthesis, the enzymatic remethylation pathway is exploited to produce L-methionine from precursors such as O-acetyl-L-homoserine or O-succinyl-L-homoserine 2,3. The key enzyme in this process is O-acetylhomoserine sulfhydrylase, which catalyzes the nucleophilic substitution of the acetyl or succinyl group by methyl mercaptan, yielding L-methionine and acetate or succinate 2,3. This enzyme exhibits broad substrate specificity and can also utilize dimethyl disulfide (DMDS) as a sulfur source, provided that DMDS is first reduced to methyl mercaptan by enzymatic hydrogenolysis 1,8. The use of DMDS offers a significant advantage in industrial settings, as it eliminates the need for on-site synthesis of methyl mercaptan from hydrogen, hydrogen sulfide, and methanol, thereby reducing capital costs and improving process safety 1,8.

The enzymatic hydrogenolysis of DMDS to methyl mercaptan is catalyzed by DMDS reductase, a flavin-dependent enzyme that requires an organic reducing compound such as glucose or NADH as an electron donor 1,8. The reaction proceeds as follows:

DMDS + 2[H] → 2 CH₃SH

The methyl mercaptan generated in situ can then be directly utilized by O-acetylhomoserine sulfhydrylase to produce L-methionine in a "one-pot" reaction, simplifying downstream processing and improving overall yield 1,8. Optimal reaction conditions for this enzymatic conversion include a methyl mercaptan partial pressure of 10–180 kPa, a temperature range of 25–37°C, and a pH of 7.0–8.5 10. Under these conditions, L-methionine yields exceeding 90% (based on O-acetyl-L-homoserine) have been reported 10.

Industrial Biosynthesis Of L-Methionine Via Enzymatic Remethylation And Precursor Conversion

The industrial production of L-methionine has increasingly shifted toward hybrid biosynthetic processes that combine microbial fermentation of L-methionine precursors with enzymatic conversion using reduced sulfur compounds 1,2,3. This approach offers several advantages over purely chemical synthesis, including the exclusive production of the L-enantiomer, reduced environmental impact, and lower energy consumption 1. The most widely adopted industrial process involves a two-stage method: (1) fermentation of recombinant microorganisms to produce O-acetyl-L-homoserine or O-succinyl-L-homoserine, and (2) enzymatic reaction of the precursor with methyl mercaptan or dimethyl disulfide (DMDS) to yield L-methionine 2,3.

In the first stage, genetically modified strains of Corynebacterium or Escherichia coli are engineered to overproduce L-methionine precursors by deregulating feedback inhibition and enhancing the expression of key biosynthetic enzymes 2,3. For example, overexpression of homoserine O-acetyltransferase (MetA) increases the flux from L-homoserine to O-acetyl-L-homoserine, while deletion of threonine synthase prevents the diversion of homoserine toward threonine biosynthesis 3. Additionally, increasing the activity of the glyoxylate shunt (via overexpression of isocitrate lyase and malate synthase) enhances acetyl-CoA availability, which is required for the acetylation of homoserine 12. These metabolic engineering strategies have enabled precursor titers exceeding 50 g/L in fed-batch fermentation, with productivities of 1–2 g/L/h 3.

In the second stage, the accumulated O-acetyl-L-homoserine is reacted with methyl mercaptan in the presence of O-acetylhomoserine sulfhydrylase to produce L-methionine and acetate 2,3. The enzyme can be supplied as purified protein, crude cell extract, or whole cells (either viable or permeabilized) 2. The use of whole cells offers the advantage of in situ cofactor regeneration and enzyme stability, but may be limited by mass transfer constraints and product inhibition 2. To address the issue of acetate accumulation (which can reach equimolar concentrations relative to L-methionine and inhibit enzyme activity), recent innovations have focused on engineering microorganisms that can simultaneously produce O-acetyl-L-homoserine and convert it to L-methionine in a single fermentation step 3. This is achieved by co-expressing L-homoserine O-acetyltransferase and O-acetylhomoserine sulfhydrylase in the same host, and by supplying methyl mercaptan or DMDS to the culture medium 3. The acetate generated during the conversion is then reassimilated by the microorganism via the acetyl-CoA synthetase pathway, thereby reducing acetate toxicity and improving overall process efficiency 3.

An alternative approach involves the use of dimethyl disulfide (DMDS) as the sulfur source, which is enzymatically reduced to methyl mercaptan by DMDS reductase in the presence of an organic reducing compound such as glucose 1,8. This "one-pot" process eliminates the need for external methyl mercaptan supply and simplifies reactor design 1,8. The reaction can be carried out in a single vessel containing the L-methionine precursor, DMDS, glucose, and a recombinant microorganism expressing both DMDS reductase and O-acetylhomoserine sulfhydrylase 1,8. Under optimized conditions (DMDS partial pressure 10–180 kPa, temperature 30–37°C, pH 7.5–8.0), L-methionine yields of 85–95% have been achieved 1,8.

Key process parameters for industrial L-methionine biosynthesis include:

  • Precursor concentration: O-acetyl-L-homoserine titers of 40–60 g/L are typical in fed-batch fermentation, with conversion efficiencies to L-methionine exceeding 90% 3.
  • Methyl mercaptan partial pressure: Optimal range is 10–180 kPa; higher pressures increase reaction rate but may cause enzyme inhibition or safety concerns 10.
  • Temperature: Enzymatic conversion is typically conducted at 25–37°C to balance enzyme activity and stability 10.
  • pH: Optimal pH is 7.0–8.5; lower pH increases und
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
ARKEMA FRANCEIndustrial biosynthesis of L-methionine for animal feed additives and pharmaceutical applications requiring sustainable production with reduced equipment footprint compared to conventional chemical synthesis.Bio-based L-Methionine Production PlatformEnzymatic conversion of L-methionine precursors with DMDS and organic reducing compounds, eliminating need for on-site methyl mercaptan synthesis, reducing capital costs and improving process safety through one-pot reaction achieving 85-95% yield.
Evonik Operations GmbHLarge-scale microbial production of L-methionine from renewable feedstocks for feed and food industries, optimizing energy balance by utilizing reduced sulfur compounds and minimizing byproduct accumulation.Fermentative L-Methionine Biosynthesis SystemEngineered microorganisms co-expressing L-homoserine O-acetyltransferase and O-acetylhomoserine sulfhydrylase enable single-step fermentation with acetate reassimilation, achieving precursor titers exceeding 50 g/L and conversion efficiencies above 90%.
CJ CheilJedangCommercial-scale production of optically pure L-methionine for animal nutrition and pharmaceutical applications, combining fermentation advantages with enzymatic specificity to avoid racemic mixture formation.Hybrid Chemical-Biological L-Methionine ProcessTwo-stage biotechnological method producing O-acetyl-L-homoserine via recombinant fermentation followed by enzymatic conversion with methyl mercaptan using O-acetylhomoserine sulfhydrylase, exclusively producing L-enantiomer with high catalytic efficiency.
BISSBORT SIEGBERT HEINRICH and DAVIS HENRY JOHNTherapeutic treatment of myalgic encephalomyelitis (chronic fatigue syndrome) and immune deficiency conditions requiring restoration of cellular methylation homeostasis and transmethylation pathway function.Methylation Capacity Enhancement FormulationL-methionine supplementation at 20-90 mg/kg body mass combined with magnesium, folic acid, vitamin B6, and vitamin B12 enhances SAM:SAH ratio from 5:1 to 20:1, restoring methylation capacity and activating immune responses.
Corynebacterium/E.coli Engineered StrainsMicrobial cell factories for sustainable L-methionine production in fermentation systems requiring reduced energy burden through utilization of reduced sulfur sources instead of inorganic sulfate reduction pathway.Recombinant Methionine Biosynthesis PlatformMetabolic engineering with deregulated feedback inhibition, enhanced glyoxylate shunt activity, and cobalamin-dependent/independent methionine synthase expression achieves homocysteine remethylation with productivities of 1-2 g/L/h.
Reference
  • Method for producing l-methionine
    PatentActiveSG11201802624YA
    View detail
  • Method for producing l-methionine
    PatentWO2017009047A1
    View detail
  • Method for producing l-methionine
    PatentActiveEP3380627B1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png